Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HAJEK

Showing results (1451-1460 of 1,751) with videos related to

Pageof 176
Sort By:
The New Phytologist|June 27, 2024
Leaf isotopes reveal tree diversity effects on the functional responses to the pan-European 2018 summer droughtXin Jing, Christel Baum, Bastien Castagneyrol, et al.
European Journal of Human Genetics : EJHG|February 29, 2024
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world settingAmanda Massmann, Kurt D Christensen, Joel Van Heukelom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 26, 2020
Atypical clinical presentation of Ebola virus disease in pregnancy: Implications for clinical and public health managementBoris I Pavlin, Andrew Hall, Jan Hajek, et al.
Blood Advances|May 20, 2022
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myelomaThomas Martin, Joseph Mikhael, Roman Hajek, et al.
The European Respiratory Journal|April 18, 2015
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quitCarlos A Jiménez-Ruiz, Stefan Andreas, Keir E Lewis, et al.
Ejhaem|July 18, 2022
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)Heinz Ludwig, Bela Hausmann, Martin Schreder, et al.
Haematologica|July 16, 2026
Teclistamab in relapsed/refractory Waldenstro m macroglobulinemiaMichal Kascak, Ludmila Muronova, Ondrej Venglar, et al.
Journal of the American Geriatrics Society|March 18, 2021
Do self-reported hearing and visual impairments predict longitudinal dementia in older adults?Alexander Pabst, Jonathan Bär, Susanne Röhr, et al.
Haematologica|August 24, 2019
Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma NetworkPhilippe Moreau, Pieter Sonneveld, Mario Boccadoro, et al.
Journal of Affective Disorders|July 14, 2019
Are older men more vulnerable to depression than women after losing their spouse? Evidence from three German old-age cohorts (AgeDifferent.de platform)Franziska Förster, Alexander Pabst, Janine Stein, et al.
Pageof 176

Showing results (1451-1460 of 1,751) with videos related to

Sort By:
Pageof 176
The New Phytologist|June 27, 2024
Leaf isotopes reveal tree diversity effects on the functional responses to the pan-European 2018 summer droughtXin Jing, Christel Baum, Bastien Castagneyrol, et al.
European Journal of Human Genetics : EJHG|February 29, 2024
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world settingAmanda Massmann, Kurt D Christensen, Joel Van Heukelom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 26, 2020
Atypical clinical presentation of Ebola virus disease in pregnancy: Implications for clinical and public health managementBoris I Pavlin, Andrew Hall, Jan Hajek, et al.
Blood Advances|May 20, 2022
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myelomaThomas Martin, Joseph Mikhael, Roman Hajek, et al.
The European Respiratory Journal|April 18, 2015
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quitCarlos A Jiménez-Ruiz, Stefan Andreas, Keir E Lewis, et al.
Ejhaem|July 18, 2022
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)Heinz Ludwig, Bela Hausmann, Martin Schreder, et al.
Haematologica|July 16, 2026
Teclistamab in relapsed/refractory Waldenstro m macroglobulinemiaMichal Kascak, Ludmila Muronova, Ondrej Venglar, et al.
Journal of the American Geriatrics Society|March 18, 2021
Do self-reported hearing and visual impairments predict longitudinal dementia in older adults?Alexander Pabst, Jonathan Bär, Susanne Röhr, et al.
Haematologica|August 24, 2019
Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma NetworkPhilippe Moreau, Pieter Sonneveld, Mario Boccadoro, et al.
Journal of Affective Disorders|July 14, 2019
Are older men more vulnerable to depression than women after losing their spouse? Evidence from three German old-age cohorts (AgeDifferent.de platform)Franziska Förster, Alexander Pabst, Janine Stein, et al.
Pageof 176